Technical Analysis for CNCR - Loncar Cancer Immunotherapy ETF

Grade Last Price % Change Price Change
grade A 26.56 -0.71% -0.19
CNCR closed up 0.99 percent on Monday, June 1, 2020, on 35 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical CNCR trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction -0.73%
NR7 Range Contraction -0.73%
MACD Bearish Signal Line Cross Bearish 3.03%
Down 3 Days in a Row Weakness 3.03%
Slingshot Bullish Bullish Swing Setup 1.84%
Overbought Stochastic Strength 1.84%
Gapped Down Weakness 1.84%
Bearish Engulfing Bearish -0.49%
New 52 Week High Strength -0.49%
Outside Day Range Expansion -0.49%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Cancer Betashares SPDR Biotechnology Sectors Loncar Cancer Immunotherapy Index

Is CNCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.0
52 Week Low 12.0
Average Volume 18,392
200-Day Moving Average 21.55
50-Day Moving Average 22.84
20-Day Moving Average 25.57
10-Day Moving Average 26.75
Average True Range 0.93
ADX 23.9
+DI 30.33
-DI 22.92
Chandelier Exit (Long, 3 ATRs ) 25.22
Chandelier Exit (Short, 3 ATRs ) 24.52
Upper Bollinger Band 28.49
Lower Bollinger Band 22.65
Percent B (%b) 0.7
BandWidth 22.83
MACD Line 1.07
MACD Signal Line 1.17
MACD Histogram -0.1034
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.43
Resistance 3 (R3) 27.36 27.07 27.32
Resistance 2 (R2) 27.07 26.90 27.11 27.28
Resistance 1 (R1) 26.91 26.79 26.77 26.98 27.24
Pivot Point 26.62 26.62 26.55 26.66 26.62
Support 1 (S1) 26.46 26.45 26.32 26.53 26.27
Support 2 (S2) 26.17 26.34 26.21 26.23
Support 3 (S3) 26.01 26.17 26.19
Support 4 (S4) 26.08